Cell Therapy Shows Remarkable Ability to Eradicate Cancer in Clinical Study
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells. The results were published today
Innovation Toronto
An early look at what is coming next – good and bad
Genetically Modified T Cells Induced Complete Remissions in 88 Percent of Advanced Leukemia Patients Treated
Innovation Toronto 
Discussion
No comments yet.